Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccines | 1 | 2021 | 64 | 0.670 |
Why?
|
| Phytoestrogens | 3 | 2018 | 40 | 0.550 |
Why?
|
| Plant Extracts | 3 | 2018 | 303 | 0.440 |
Why?
|
| Menopause | 2 | 2010 | 63 | 0.400 |
Why?
|
| Acanthaceae | 1 | 2010 | 2 | 0.330 |
Why?
|
| North Carolina | 4 | 2025 | 122 | 0.330 |
Why?
|
| Premenstrual Syndrome | 1 | 2010 | 13 | 0.330 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 184 | 0.280 |
Why?
|
| Patient Satisfaction | 3 | 2020 | 163 | 0.280 |
Why?
|
| Breast Neoplasms | 5 | 2020 | 1679 | 0.230 |
Why?
|
| Problem-Based Learning | 1 | 2025 | 41 | 0.230 |
Why?
|
| Career Choice | 1 | 2025 | 51 | 0.230 |
Why?
|
| Mastectomy, Segmental | 2 | 2020 | 25 | 0.190 |
Why?
|
| Phytotherapy | 3 | 2018 | 78 | 0.190 |
Why?
|
| Indians, North American | 1 | 2023 | 179 | 0.170 |
Why?
|
| Biomedical Research | 1 | 2025 | 467 | 0.160 |
Why?
|
| Pimenta | 1 | 2018 | 1 | 0.150 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2018 | 19 | 0.150 |
Why?
|
| Chromones | 1 | 2018 | 53 | 0.140 |
Why?
|
| Psychometrics | 1 | 2020 | 350 | 0.140 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2018 | 134 | 0.130 |
Why?
|
| Humans | 13 | 2025 | 42163 | 0.120 |
Why?
|
| Quality of Life | 2 | 2020 | 599 | 0.120 |
Why?
|
| Mammaplasty | 1 | 2014 | 7 | 0.110 |
Why?
|
| Mastectomy | 1 | 2014 | 16 | 0.110 |
Why?
|
| Self Efficacy | 1 | 2016 | 211 | 0.110 |
Why?
|
| Health Records, Personal | 1 | 2014 | 6 | 0.110 |
Why?
|
| Comparative Effectiveness Research | 1 | 2014 | 15 | 0.110 |
Why?
|
| Receptors, Estrogen | 2 | 2018 | 177 | 0.110 |
Why?
|
| Researcher-Subject Relations | 1 | 2013 | 3 | 0.110 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 107 | 0.110 |
Why?
|
| Altruism | 1 | 2013 | 12 | 0.110 |
Why?
|
| Research Subjects | 1 | 2013 | 34 | 0.100 |
Why?
|
| Female | 10 | 2025 | 24018 | 0.100 |
Why?
|
| Genes, Reporter | 2 | 2010 | 148 | 0.100 |
Why?
|
| Receptors, Progesterone | 2 | 2010 | 90 | 0.100 |
Why?
|
| Research | 1 | 2013 | 177 | 0.090 |
Why?
|
| Estradiol | 2 | 2010 | 269 | 0.090 |
Why?
|
| Dysmenorrhea | 1 | 2010 | 3 | 0.080 |
Why?
|
| Plant Components, Aerial | 1 | 2010 | 5 | 0.080 |
Why?
|
| Herbal Medicine | 1 | 2010 | 8 | 0.080 |
Why?
|
| Progestins | 1 | 2010 | 12 | 0.080 |
Why?
|
| Genes | 1 | 2010 | 56 | 0.080 |
Why?
|
| Gene Expression | 2 | 2010 | 692 | 0.080 |
Why?
|
| Cyclooxygenase 2 | 1 | 2010 | 106 | 0.080 |
Why?
|
| Neoplasms | 1 | 2018 | 1341 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2010 | 2598 | 0.060 |
Why?
|
| Preceptorship | 1 | 2025 | 10 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2025 | 73 | 0.060 |
Why?
|
| Binding, Competitive | 2 | 2018 | 107 | 0.060 |
Why?
|
| Middle Aged | 4 | 2023 | 11819 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2023 | 428 | 0.050 |
Why?
|
| Trust | 1 | 2023 | 157 | 0.050 |
Why?
|
| Young Adult | 2 | 2023 | 4936 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2023 | 526 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 638 | 0.040 |
Why?
|
| Male | 3 | 2025 | 22779 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2018 | 98 | 0.040 |
Why?
|
| Logistic Models | 1 | 2021 | 1001 | 0.040 |
Why?
|
| Plants, Medicinal | 1 | 2018 | 60 | 0.040 |
Why?
|
| Plant Leaves | 1 | 2018 | 134 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2018 | 160 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2023 | 959 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 1058 | 0.030 |
Why?
|
| Adult | 2 | 2023 | 13458 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2016 | 46 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1112 | 0.030 |
Why?
|
| Breast Implantation | 1 | 2014 | 1 | 0.030 |
Why?
|
| Linear Models | 1 | 2014 | 311 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3077 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2014 | 99 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2014 | 158 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 1139 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1420 | 0.020 |
Why?
|
| Decision Making | 1 | 2014 | 242 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 1586 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 1729 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2014 | 309 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 1541 | 0.020 |
Why?
|
| Aged | 1 | 2023 | 7982 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 5950 | 0.020 |
Why?
|
| Costa Rica | 1 | 2009 | 9 | 0.020 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2009 | 11 | 0.020 |
Why?
|
| Estrogen Receptor beta | 1 | 2009 | 39 | 0.020 |
Why?
|
| Luciferases | 1 | 2009 | 70 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2009 | 120 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 526 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 222 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2009 | 1265 | 0.010 |
Why?
|
| United States | 1 | 2013 | 5072 | 0.010 |
Why?
|